Top-News
Montag,
25.01.2016 10:10
von
GlobeNewswire
| Aufrufe: 686
Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
Forschungsteam bei der Arbeit im Labor (Symbolbild).
© gorodenkoff / iStock / Getty Images Plus / Getty Images
http://www.gettyimages.de
Medigene AG / Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
| X Notification of Major Holdings or Correction of a notification of Major Holding published on (date of publication) |
| 1. Details of issuer (name, address) Medigene AG Lochhamer Str. 11 82152 Planegg/Martinsried Germany |
| 2. Reason for notification (multiple reasons possible) Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason: Restatement of interest in line with Transparency Directive amendments, also § 41 Abs. 4f WpHG |
3. Details of person subject to the notification obligation
| Name: Aviva plc | City and country of registered office (if applicable): London, United Kingdom |
| 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. Aviva Life & Pensions UK Ltd. |
| 5. Date on which threshold was crossed or reached: 26.11.2015 |
| 6. Total positions | ||||
| % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | total of both in % (7.a. + 7.b.) | total number of voting rights of issuer | |
| Resulting situation | 7.63% | 2.21% | 9.84% | 19,678,221 |
| Previous notification (if applicable) | 9.72% | N/A% | N/A% | |
| 7. Notified details of the resulting situation | ||||
| a. Voting rights attached to shares (Sec.s 21, 22 WpHG) | ||||
| ISIN | absolute | in % | ||
| direct (Sec. 21 WpHG) | indirect (Sec. 22 WpHG) | direct (Sec. 21 WpHG) | indirect (Sec. 22 WpHG) | |
| DE000A1X3W00 | 0 | 1502268 | 0% | 7.63% |
| % | % | |||
| Total | 1502268 | 7.63% | ||
| b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG (please use annex in case of more than 3 instruments) | ||||
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
| RIGHT TO RECALL LOANED SHARES | N/A | N/A | 433837 | 2.21% |
| % | ||||
| % | ||||
| Total | 433837 | 2.21% | ||
| b.2 Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG (please use annex in case of more than 3 instruments) | |||||
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
| % | |||||
| % | |||||
| % | |||||
| Total | % | ||||
| 8. Information in relation to the person subject to the notification obligation (please tick the applicable box): Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity (please use annex in case of more than 4 undertakings; in this case please always provide only to BaFin also an organizational chart accompanying your notification): | |||
| Name | % of voting rights (if at least held 3% or more) | % of voting rights through instruments (if at least held 5% or more) | Total of both (if at least held 5% or more) |
| See annex | % | % | % |
| % | % | % | |
| % | % | % | |
| % | % | % | |
| 9. In case of proxy voting according to § 22 Abs. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights) |
Attachment to (please tick the applicable box)
II.7.b.1. (fill in the sums into the standard form)
| 7.b.1. Instrumente i.S.d. Sec. 25 para. 1 No. 1 WpHG (attachment can be extended) | ||||
| Type of instrument | Voting rights absolute | Voting rights in % | Expiration or maturity date | Exercise or conversion period |
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
| % | ||||
II.7.b.2. (fill in the sums into the standard form)
| 7.b.2. Instrumente i.S.d. Sec. 25 Abs. 1 No. 2 WpHG (attachment can be extended) | |||||
| Type of instrument | Voting rights absolute | Voting rights in % | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement |
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
| % | |||||
X II.8. (Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity; attachment can be extended)
| Name | % of voting rights (if at least held 3% or more) | % of voting rights through instruments (if at least held 5% or more) | Total of both (if at least held 5% or more) |
| Aviva plc | % | % | % |
| Aviva Group Holdings Ltd | % | % | % |
| Aviva Participations SA | % | % | % |
| Aviva France SA | % | % | % |
| % | % | % | |
| Aviva plc | % | % | % |
| Aviva Group Holdings Ltd | % | % | % |
| Aviva Life Holdings UK Ltd | % | % | % |
| Aviva Life & Pensions UK Ltd | 5.34% | % | 7.36% |
| % | % | % | |
| Aviva plc | % | % | % |
| Aviva Group Holdings Ltd | % | % | % |
| Aviva Investors Holdings Ltd | % | % | % |
| Aviva Investors Luxembourg SA | % | % | % |
| % | % | % | |
| Aviva plc | % | % | % |
| Aviva Group Holdings Ltd | % | % | % |
| Aviva Investors Holdings Ltd | % | % | % |
| Aviva Investors Global Services Ltd | % | % | % |
| Aviva Investors Investment Funds ICVC | % | % | % |
| % | % | % | |
| Aviva plc | % | % | % |
| Aviva Group Holdings Ltd | % | % | % |
| Aviva Investors Holdings Ltd | % | % | % |
| Aviva Investors Global Services Ltd | % | % | % |
| Aviva Investors International Fund | % | % | % |
Planegg-Martinsried, 22.01.2016
The Executive Management Board
Contact Medigene AG
Public & Investor Relations
Julia Hofmann / Dr. Robert Mayer
Email: investor@medigene.com
Tel.: ++49 - 89 - 20 00 33 33 01
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire
HUG#1980955
--- End of Message ---
Medigene AG
Lochhamer Strasse 11 Martinsried / München Germany
WKN: A1X3W0;ISIN: DE000A1X3W00;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
Werbung
Mehr Nachrichten zur Medigene Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
Andere Nutzer interessierten sich auch für folgende News
